🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Myasthenia Gravis

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod NCT07072988Phase 49 sites📍 Nice📍 Créteil📍 Garches Centre Hospitalier Universitaire de Nice · Tests: Efgartigimod Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG) NCT07215650Phase 110 sites📍 Fuzhou📍 Guangzhou📍 Guangzhou Candid Therapeutics · Tests: Cizutamig A Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy NCT07595653n/a30 sites📍 Acquaviva delle Fonti📍 Ancona📍 Bari argenx Efgartigimod in IVIG Dependent Myasthenia Gravis Patients NCT06765161Phase 31 site📍 Gatineau Clinique Neuro-Outaouais · Tests: efgartigimod administration Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment NCT06866483n/a1 site📍 Evanston ZS Associates · Tests: Social media recruitment, Self-Assessment, Follow-up A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis. NCT06447597Phase 2, Phase 318 sites📍 Beijing📍 Changchun📍 Changsha Shanghai Jiaolian Drug Research and Development Co., Ltd · Tests: B007, Placebo A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis NCT07250750Phase 1, Phase 225 sites📍 Altamonte Springs📍 Boca Raton📍 Naples ImmunAbs Inc. · Tests: IM-101 Part A, Placebo Part A, IM-101 Part B, Placebo Part B AXIS MG Patient Registry NCT07761026n/a1 site📍 Framingham Autoimmune Neurology Alliance Myasthenia Gravis Foundation of America Global MG Patient Registry NCT06617741n/a1 site📍 Westborough Myasthenia Gravis Foundation of America Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis NCT06491238NA1 site📍 Saint Paul HealthPartners Institute · Tests: Light Intensity Exercise, Moderate Intensity Exercise Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis NCT07146425n/a1 site📍 Shanghai Huashan Hospital PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis NCT06607627Phase 313 sites📍 Washington D.C.📍 Norfolk📍 Joinville Alexion Pharmaceuticals, Inc. · Tests: Gefurulimab The EXPLORE MG Registry for Myasthenia Gravis NCT03792659n/a1 site📍 New Haven Yale University · Tests: Blood Sample Draw Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders NCT07089121Phase 1, Phase 23 sites📍 Washington D.C.📍 St Louis📍 Cincinnati Cartesian Therapeutics · Tests: Descartes-08 A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis NCT04951622Phase 3112 sites📍 Paradise Valley📍 Scottsdale📍 Los Angeles Janssen Research & Development, LLC · Tests: Nipocalimab, Placebo, Nipocalimab SC-LIV Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab) NCT07570589n/a11 sites📍 Nice📍 Angers📍 Boulogne-sur-Mer Centre Hospitalier Universitaire de Nice · Tests: Patients diagnosed with generalized myasthenia gravis and treated with Rozanolixizumab Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment NCT07304154Phase 110 sites📍 Newport Beach📍 Palo Alto📍 New York Kite, A Gilead Company · Tests: KITE-363, Fludarabine, Cyclophosphamide A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding. NCT06299748n/a4 sites📍 Morgantown📍 Bochum📍 Roma argenx · Tests: Efgartigimod CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases NCT07337785EARLY Phase 11 site📍 Wuhan Tongji Hospital · Tests: CD19/BCMA-targeted CAR-T cells, Lymphodepleting Conditioning Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases NCT07085676Phase 11 site📍 Jerusalem Polina Stepensky · Tests: HBI0101 CART Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia NCT07247279n/a7 sites📍 Kazan'📍 Moscow📍 Novosibirsk AstraZeneca ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis NCT07294170n/a37 sites📍 Carlsbad📍 Miami📍 Miami argenx · Tests: Efgartigimod IV, Empasiprubart IV, Placebo IV, Efgartigimod PH20 SC PFS A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis NCT06392386Phase 2, Phase 322 sites📍 Charlotte📍 Denton📍 Charlottesville argenx · Tests: Efgartigimod PH20 SC A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG) NCT07673744Phase 27 sites📍 Colorado Springs📍 Colorado Springs📍 Clearwater TG Therapeutics, Inc. · Tests: Ublituximab, Placebo A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG) NCT06909214Phase 418 sites📍 La Jolla📍 Rancho Mirage📍 Boca Raton argenx · Tests: Efgartigimod PH20 SC Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis NCT06064695NA2 sites📍 Fairway📍 Columbia University of Missouri-Columbia · Tests: Whole-body Electrical Muscle Stimulation Exercise A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG) NCT06987539Phase 214 sites📍 Chicago📍 Philadelphia📍 Austin Amgen · Tests: Inebilizumab Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA) NCT06940323n/a1 site📍 San Francisco University of California, San Francisco Study of Ultomiris® (Ravulizumab) Safety in Pregnancy NCT06312644n/a7 sites📍 Boston📍 Melbourne📍 Paris Alexion Pharmaceuticals, Inc. · Tests: Ultomiris
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy